Clinical Trial Update: Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an 8-week course of sofosbuvir/velpatasvir for acute hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Hannover Medical School | Conditions: Hepatitis C, Acute Hepatitis C | Phase 2 | Status: COMPLETED